Prosecution Insights
Last updated: May 29, 2026

Examiner: ROBINSON, HOPE A

Tech Center 1600 • Art Units: 1652 1656

This examiner grants 68% of resolved cases

Performance Statistics

67.9%
Allow Rate
+7.9% vs TC avg
1,108
Total Applications
+43.2%
Interview Lift
1210
Avg Prosecution Days
Based on 1036 resolved cases, 2023–2026

Rejection Statute Breakdown

4.4%
§101 Eligibility
18.8%
§102 Novelty
25.2%
§103 Obviousness
41.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18419342 ENHANCING THE SEQUESTRATION OF CARBON DIOXIDE IN DOWNHOLE CARBONATE-BASED RESERVOIRS VIA INJECTING UREASE ENZYME Non-Final OA SAUDI ARABIAN OIL COMPANY
19317818 PLATFORM FOR BIO-BASED PRODUCTION OF HIGH LEVELS OF O-PHOSPHOSERINE, CYSTEATE, OR TAURINE Final Rejection Natáur Inc.
19303717 KITS AND METHODS FOR BIOLOGICAL SAMPLE PROCESSING Non-Final OA GEN-PROBE INCORPORATED
19275193 IMMOBILIZED ENZYMES FOR THE BIOELECTRIC PRODUCTION OF FORMATE AND FORMIC ACID Non-Final OA Anodyne Chemistries, Inc.
18262318 METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE Non-Final OA Kashiv BioSciences, LLC
18430193 Composition and Method for Increasing Fatty Acid Production in Cyanobacteria by Altering Cell Membrane Permeability Non-Final OA Morgan State University
18002239 NOVEL TRANSGLUTAMINASE Final Rejection THE UNIVERSITY OF TOKYO
18598468 IL-1RA CDNAS Non-Final OA University of Florida Research Foundation, Incorporated
18976903 SINGLE CELL PROTEIN WITH ENHANCED POLYUNSATURATED FATTY ACID CONTENT Final Rejection LanzaTech, Inc.
18546061 FUSION PROTEINS COMPRISING A PROTEIN WITH PHASE BEHAVIOR Non-Final OA Donaldson Company, Inc.
18265094 ENZYME BASED PRODUCTION OF SPECIALIZED PRO-RESOLVING MEDIATORS (SPMS) VIA DOCOSAHEXAENOIC ACID (DHA) AND EICOSAPENTAENOIC ACID (EPA) Non-Final OA Evonik Operations GmbH
18005086 POLYNUCLEOTIDE ENCODING AN AMINO ACID SEQUENCE, ENCODING AN OXIDOREDUCTASE Non-Final OA Evonik Operations GmbH
18191994 MUTANT TRANSGLUTAMINASE Non-Final OA AJINOMOTO CO., INC.
17807998 METHOD FOR MANUFACTURING FERMENTATION PRODUCTS, AND SENSOR DEVICE USED FOR SAME Non-Final OA AJINOMOTO CO., INC.
18720533 PRODUCTION OF ALPHA-1,4-FUCOSYLATED COMPOUNDS Final Rejection INBIOSE N.V.
17910952 TRANSGLUTAMINASE VARIANTS Non-Final OA Curie Co. Inc.
17623086 MODIFIED YEAST CELLS THAT OVER-EXPRESS SELECTED ENDOGENOUS PROTEINS Non-Final OA DANISCO US INC
18698789 KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES Non-Final OA UNIVERSITE PARIS-SACLAY
18012979 ENZYME-IMMOBILIZATION CARRIER AND IMMOBILIZED ENZYME THAT USES SAME Final Rejection FUJI OIL HOLDINGS INC.
17416752 Tandem Protein Expression Non-Final OA Novozymes A/S
17997932 PECTIN EXTRACTION PROCESS Final Rejection DUPONT NUTRITION BIOSCIENCES APS
18416322 COMPOSITIONS AND METHODS FOR AMINO ACID DEPLETION THERAPY Final Rejection AVALON POLYTOM (HK) LIMITED
17607543 METHODS FOR PRODUCTION OF ERGOTHIONEINE Non-Final OA Danmarks Tekniske Universitet
17916441 ADAMTS13 VARIANT, COMPOSITIONS, AND USES THEREOF Final Rejection TAKEDA PHARMACEUTICAL COMPANY LIMITED
18068004 BACTERIA ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA Non-Final OA Synlogic Operating Company, Inc.
18557508 PRETREATMENT METHOD FOR QUANTITATIVE DETECTION OF UNDENATURED TYPE II COLLAGEN IN COLLAGEN PRODUCT OR CARTILAGE, AND APPLICATION Final Rejection ANHUI SEMNL BIOTECHNOLOGY CO., LTD.
17526464 METHOD OF PRODUCING MICROBIAL OIL CONTAINING FATTY ACIDS OBTAINED FROM LABYRINTHULID GENETICALLY MODIFIED BY GENE DISRUPTING OR TRANSFORMATION Non-Final OA NIPPON SUISAN KAISHA, LTD.
16624523 IMMUNOPRIVILEGED BIOACTIVE RENAL CELLS FOR THE TREATMENT OF KIDNEY DISEASE Final Rejection ProKidney
17843589 NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY Non-Final OA Genomatica, Inc.
16767920 METHODS OF TREATMENT WITH ASPARAGINASE Non-Final OA JAZZ PHARMACEUTICALS IRELAND LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month